United Therapeutics Corporation (UTHR) Gross margin 2016–2025
United Therapeutics Corporation (UTHR) gross margin by fiscal year — reported gross profit divided by reported revenue.
87.9%FY2025 · since FY2016: 95.5% → 87.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 87.9% | -1.3 pp |
| FY2024 | 89.2% | +0.3 pp |
| FY2023 | 88.9% | -3.2 pp |
| FY2022 | 92.2% | -0.6 pp |
| FY2021 | 92.7% | +0.0 pp |
| FY2020 | 92.7% | +0.8 pp |
| FY2019 | 91.9% | +4.1 pp |
| FY2018 | 87.8% | -6.1 pp |
| FY2017 | 93.9% | -1.6 pp |
| FY2016 | 95.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More UTHR financial trends
UTHR RevenueUTHR Net incomeUTHR Net marginUTHR Gross profitUTHR Operating incomeUTHR Operating marginUTHR Operating cash flowUTHR Free cash flowUTHR Capital expendituresUTHR Return on equityUTHR Stock buybacksUTHR Dividends paidUTHR Total assetsUTHR Total liabilitiesUTHR Shareholders’ equityUTHR overview →